DiNuzzo Private Wealth
MRNA icon

DiNuzzo Private Wealth’s Moderna MRNA Stock Holding History

DiNuzzo Private Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.55K Buy
34
+4
+13% +$431 ﹤0.01% 362
2026
Q2 		$2.1K Buy
30
+7
+30% +$362 ﹤0.01% 658
2026
Q1 		$1.17K Buy
+23
New +$1.07K ﹤0.01% 831
2025
Q2 		– Sell
-1
Closed -$29 – 1391
2025
Q1 		$29 Sell
1
-1
-50% -$35 ﹤0.01% 1354
2024
Q4 		$84 Sell
2
-16
-89% -$765 ﹤0.01% 1345
2024
Q3 		$1.2K Sell
18
-3
-14% -$275 ﹤0.01% 791
2024
Q2 		$2.49K Buy
21
+5
+31% +$633 ﹤0.01% 443
2024
Q1 		$1.7K Sell
16
-1
-6% -$101 ﹤0.01% 530
2023
Q4 		$1.69K Buy
+17
New +$1.43K ﹤0.01% 509

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

DiNuzzo Private Wealth's MRNA Position: Q3 2026 in Review

DiNuzzo Private Wealth increased its Moderna (MRNA) stake by 13% in Q3 2026, buying an estimated $431 and bringing the position to 34 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

DiNuzzo Private Wealth first reported a position in MRNA in Q4 2023 and has held it in 9 quarters since. 304 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • DiNuzzo Private Wealth held 34 shares of Moderna worth $6.55K as of Q3 2026.
  • DiNuzzo Private Wealth bought 4 Moderna shares in Q3 2026, an estimated $431.
  • Moderna made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #362 holding.
  • DiNuzzo Private Wealth first reported a position in Moderna in Q4 2023 and has held it in 9 quarters since.
  • 304 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.